BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16127034)

  • 1. Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicans.
    Chau AS; Gurnani M; Hawkinson R; Laverdiere M; Cacciapuoti A; McNicholas PM
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3646-51. PubMed ID: 16127034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid substitutions in the Candida albicans sterol Δ5,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence.
    Morio F; Pagniez F; Lacroix C; Miegeville M; Le Pape P
    J Antimicrob Chemother; 2012 Sep; 67(9):2131-8. PubMed ID: 22678731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Upc2p-Inducible
    Luna-Tapia A; Willems HME; Parker JE; Tournu H; Barker KS; Nishimoto AT; Rogers PD; Kelly SL; Peters BM; Palmer GE
    mBio; 2018 May; 9(3):. PubMed ID: 29789366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulence.
    Vale-Silva LA; Coste AT; Ischer F; Parker JE; Kelly SL; Pinto E; Sanglard D
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1960-8. PubMed ID: 22252807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Titration of C-5 Sterol Desaturase Activity Reveals Its Relationship to Candida albicans Virulence and Antifungal Susceptibility Is Dependent upon Host Immune Status.
    Regan J; DeJarnette C; Luna-Tapia A; Parker JE; Reitler P; Barnett S; Tucker KM; Kelly SL; Palmer GE
    mBio; 2022 Apr; 13(2):e0011522. PubMed ID: 35380453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluconazole treatment is effective against a Candida albicans erg3/erg3 mutant in vivo despite in vitro resistance.
    Miyazaki T; Miyazaki Y; Izumikawa K; Kakeya H; Miyakoshi S; Bennett JE; Kohno S
    Antimicrob Agents Chemother; 2006 Feb; 50(2):580-6. PubMed ID: 16436713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of C-5 Sterol Desaturase Activity in
    Luna-Tapia A; Butts A; Palmer GE
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
    Martel CM; Parker JE; Bader O; Weig M; Gross U; Warrilow AG; Rolley N; Kelly DE; Kelly SL
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4527-33. PubMed ID: 20733039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents.
    Sanglard D; Ischer F; Parkinson T; Falconer D; Bille J
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2404-12. PubMed ID: 12878497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
    Rybak JM; Dickens CM; Parker JE; Caudle KE; Manigaba K; Whaley SG; Nishimoto AT; Luna-Tapia A; Roy S; Zhang Q; Barker KS; Palmer GE; Sutter TR; Homayouni R; Wiederhold NP; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-Specific Differences in C-5 Sterol Desaturase Function Influence the Outcome of Azole Antifungal Exposure.
    Luna-Tapia A; Parker JE; Kelly SL; Palmer GE
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0104421. PubMed ID: 34516249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, sequencing, expression and allelic sequence diversity of ERG3 (C-5 sterol desaturase gene) in Candida albicans.
    Miyazaki Y; Geber A; Miyazaki H; Falconer D; Parkinson T; Hitchcock C; Grimberg B; Nyswaner K; Bennett JE
    Gene; 1999 Aug; 236(1):43-51. PubMed ID: 10433965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ERG2 and ERG24 Are Required for Normal Vacuolar Physiology as Well as Candida albicans Pathogenicity in a Murine Model of Disseminated but Not Vaginal Candidiasis.
    Luna-Tapia A; Peters BM; Eberle KE; Kerns ME; Foster TP; Marrero L; Noverr MC; Fidel PL; Palmer GE
    Eukaryot Cell; 2015 Oct; 14(10):1006-16. PubMed ID: 26231054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the Candida albicans CYB5 gene results in increased azole sensitivity.
    Rogers KM; Pierson CA; Culbertson NT; Mo C; Sturm AM; Eckstein J; Barbuch R; Lees ND; Bard M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3425-35. PubMed ID: 15328107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of ERG3 mutations and expression of ergosterol genes controlled by UPC2 and NDT80 in Candida parapsilosis azole resistance.
    Branco J; Ola M; Silva RM; Fonseca E; Gomes NC; Martins-Cruz C; Silva AP; Silva-Dias A; Pina-Vaz C; Erraught C; Brennan L; Rodrigues AG; Butler G; Miranda IM
    Clin Microbiol Infect; 2017 Aug; 23(8):575.e1-575.e8. PubMed ID: 28196695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efg1 involved in drug resistance by regulating the expression of ERG3 in Candida albicans.
    Lo HJ; Wang JS; Lin CY; Chen CG; Hsiao TY; Hsu CT; Su CL; Fann MJ; Ching YT; Yang YL
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1213-5. PubMed ID: 15728931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance genes and trailing growth in Candida albicans isolates.
    Lee MK; Williams LE; Warnock DW; Arthington-Skaggs BA
    J Antimicrob Chemother; 2004 Feb; 53(2):217-24. PubMed ID: 14688046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterols in Candida albicans mutants resistant to polyene or azole antifungals, and of a double mutant C. albicans 6.4.
    Hitchcock CA; Russell NJ; Barrett-Bee KJ
    Crit Rev Microbiol; 1987; 15(1):111-5. PubMed ID: 3319418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
    Niimi K; Monk BC; Hirai A; Hatakenaka K; Umeyama T; Lamping E; Maki K; Tanabe K; Kamimura T; Ikeda F; Uehara Y; Kano R; Hasegawa A; Cannon RD; Niimi M
    J Antimicrob Chemother; 2010 May; 65(5):842-52. PubMed ID: 20233776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Azole resistance in Candida albicans].
    Perea S
    Rev Esp Quimioter; 2000 Sep; 13(3):314-7. PubMed ID: 11086283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.